Increased Circulating Endothelin-1 in Rheumatic Mitral Stenosis: Irrelevance to Left Atrial and Pulmonary Artery Pressures

Chest

Volumn 125, Issue 2, 2004, Pages 390-396

  Chen, Mien Cheng ^a   Wu, Chiung Jen ^a   Yip, Hon Kan ^a   Chang, Hsueh Wen ^b   Chen, Chien Jen ^a   Yu, Teng Hung ^a   Hung, Wei Chin ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Endothelin 1; Mitral stenosis

Indexed keywords

BIOLOGICAL MARKER; ENDOTHELIN 1;

ADULT; AGE; AGED; ANALYSIS OF VARIANCE; ARTICLE; BALLOON DILATATION; BLOOD LEVEL; BLOOD SAMPLING; CASE CONTROL STUDY; CLINICAL ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DOPPLER ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMORAL ARTERY; FEMORAL VEIN; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART LEFT ATRIUM PRESSURE; HEART RIGHT ATRIUM; HEMODYNAMICS; HOSPITALIZATION; HUMAN; LUNG ARTERY PRESSURE; LUNG CIRCULATION; MALE; METHODOLOGY; MITRAL VALVE; MITRAL VALVE STENOSIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHYSIOLOGY; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; PROBABILITY; REFERENCE VALUE; RHEUMATIC HEART DISEASE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SINUS RHYTHM; STATISTICAL MODEL; TREATMENT OUTCOME; VASCULAR RESISTANCE; VENOUS BLOOD;

EID: 1242306667     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.2.390     Document Type: Article

References (15)

1. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332:411-415
2. Lerman A, Edwards BS, Hallett JW, et al. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 1991; 325:997-1001
3. Wei CM, Lerman A, Rodeheffer RJ, et al. Endothelin in human congestive heart failure. Circulation 1994; 89:1580-1586
4. Kiowski W, Sutsch G, Hunziker P, et al. Evidence for endothelin-1- mediated vasoconstriction in severe chronic heart failure. Lancet 1995; 346:732-736
5. Yamamoto K, Ikeda U, Mito H, et al. Endothelin production in pulmonary circulation of patients with mitral stenosis. Circulation 1994; 89:2093-2098
6. Kinoshita O, Yoshimi H, Nagata S, et al. Rapid increase in plasma endothelin concentrations during percutaneous balloon dilatation of the mitral valve in patients with mitral stenosis. Br Heart J 1993; 69:322-326
7. Wagner OF, Nowotny P, Vierhapper H, et al. Plasma concentrations of endothelin in man: arterio-veuous differences and release during venous stasis. Eur J Clin Invest 1990; 20:502-505
8. Jui-Sung Hung. Atrial septal puncture technique in percutaneous transluminal mitral commissurotomy: mitral valvuloplasty using the Inoue balloon catheter technique. Cachet Cardiovasc Diagn 1992; 26:275-284
9. Lin JJ, Huang CX, Fang CH, et al. Circadian variation in ischemic threshold inpatients with stable angina: relation to plasma endothelin-1. Angiology 2002; 53:409-413
10. Suzuki N, Matsumoto H, Miyauchi T, et al. Sandwich-enzyme immunoassays for endothelin family peptides. J Cardiovasc Pharmacol 1991; 17:S420-S422
11. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 1994; 46:325-415
12. Dupuis J, Cernacek P, Tardif JC, et al. Reduced pulmonary clearance of endothelin-1 in pulmonary hypertension. Am Heart J 1998; 135:614-620
13. Nucci GD, Thomas R, D'Orleans-Juste P, et al. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988; 85:9797-9800
14. Guilherme L, Cunha-Neto E, Tanaka AC, et al. Heart-directed autoimmunity: the case of rheumatic fever. J Autoimmun 2001; 16:363-367
15. Brundel BJJM, Van Gelder IC, Tuinenburg AE, et al. Endothelin system in human persistent and paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 2001; 12:737-742